Immunophenotypings of malignant epithelial mesothelioma and their roles in the differential diagnosis

Abstract

To investigate the immunophenotypings of malignant epithelial mesothelioma (MEM), and to seek the valuable markers in distinguishing peritoneal MEM from peritoneal metastatic ovarian adenocarcinoma (OA) and colorectal adenocarcinoma (CA), immunohistochemical SP method was used to detect expressions of HBME-1, E-cadherin, CA19-9, MOC-31 and CK7 in paraffinembedded tissues of 18 cases of MEM, 20 OA and 20 CA. The results showed that there was a significant difference in the expressions of E-cadherin, CA19-9 and MOC-31 between MEM and OA group (P<0.05). Similarly, the difference in the expression of HBME-1, E-cadherin, CA19-9, MOC-31 and CK7 between MEM and CA groups is significant (P<0.05). These results indicate that HBME-1 could be used as a positive marker in distinguishing MEM from CA. E-cadherin, CA19-9 and MOC-31 are considered to be useful negative markers in diagnostic distinction between MEM and metastatic adenocarcinomas, including OA and CA. CK7 is the best positive marker in distinguishing MEM from CA, but this marker appears to be valueless in discriminating MEM from OA.

Keywords

malignant mesothelioma / metastatic adenocarcinoma / immunophenotyping / HBME-1 / E-cadherin / CA19-9 / MOC-31 / CK7

References

[1] AttanoosR L, GibbsA R. Primary malignant gonadal mesotheliomas and asbestos. Histopathology, 2000, 37(2): 150-150

[2] WatanabeM, SyzukH, FukutomeK, et al. . An autopsy case of a malignant pericardial mesothelioma in a Japanese young man. Pathol Int, 1999, 49658-658

[3] OrdonezN G. Role of immunohistochemistry in distin-guishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serouscarcinomas. Am J Surg Pathol, 1998, 22(10): 1203-1203

[4] WickM R. Editorial: Immunophenotying of malignant mesothelioma. Am J Surg Pathol, 1997, 211395-1395

[5] MiettinenM, KvatichA J. HBME-1: a monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocarcinoma and soft tissue and bone tumor. Appl Immunohistochem, 1995, 3115-115

[6] AttanoosK L, GoddardH, GibbsA R. Mesothelioma-binding antibody: thrombomodulin, OU632 and HBME-1 and their use in the diagnosis of malignant mesothelioma. Histopathology, 1996, 29209-209

[7] TakeichiM. Cadherin cell adhersion receptors as a morphogenetic regulator. Science, 1991, 251(8): 1451-1451

[8] HanA C, SolerA P, KnudsenK A, et al. . Differential expression of N-cadherin in pleural mesothelioma and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues. Hum Pathol, 1997, 28641-641

[9] SouhamiR L, BeverleyP L C, BobrowL G. Antigens of small lung cancer. First Intenational Workshop Lancet, 1987, 2325-325

[10] EdwardsC, OatesJ. OV632 and MOC-31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin-fixed and paraffin wax embedded material. J Clin Pathol, 1995, 48626-626

[11] UedaG, SawadaM, OgawaH, et al. . Immunohisto-chemical study of cytokeratin 7 for the differential diagnosis of adenocarcinoma in the ovary. Gynecol Oncol, 1993, 51219-219